Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.35% | 8.94% | 13.60% | 16.81% | 22.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.35% | 8.94% | 13.60% | 16.81% | 22.05% |
| Cost of Revenue | -6.83% | 0.97% | 8.33% | 15.72% | 24.97% |
| Gross Profit | 6.40% | 10.39% | 14.55% | 17.01% | 21.53% |
| SG&A Expenses | 7.75% | 15.37% | 17.94% | 17.96% | 16.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.01% | 9.32% | 12.30% | 13.99% | 13.88% |
| Operating Income | 30.73% | 3.02% | 41.21% | 172.13% | 389.66% |
| Income Before Tax | 18.02% | -11.16% | 12.39% | 40.36% | 589.12% |
| Income Tax Expenses | -1,258.43% | -1,330.56% | -1,712.56% | 86.03% | 124.92% |
| Earnings from Continuing Operations | 154.22% | 97.18% | 171.77% | 34.82% | 783.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 154.22% | 97.18% | 171.77% | 34.82% | 783.73% |
| EBIT | 30.73% | 3.02% | 41.21% | 172.13% | 389.66% |
| EBITDA | 36.68% | 14.98% | 52.26% | 168.37% | 598.11% |
| EPS Basic | 161.83% | 102.92% | 180.17% | 34.90% | 785.52% |
| Normalized Basic EPS | 13.45% | -3.04% | 22.43% | 62.67% | 636.41% |
| EPS Diluted | 168.46% | 107.51% | 189.20% | 36.16% | 852.96% |
| Normalized Diluted EPS | 15.57% | -1.23% | 25.21% | 63.97% | 671.93% |
| Average Basic Shares Outstanding | -2.61% | -2.23% | -1.32% | -0.31% | 0.58% |
| Average Diluted Shares Outstanding | -3.91% | -4.16% | -2.28% | -0.60% | 1.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |